News
18h
Verywell Health on MSNOhtuvayre: The First Novel COPD Treatment Approved in Over a DecadeOhtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...
2d
Verywell Health on MSNVaping May Seem Safer Than Cigarette Smoking, but It Still Raises Lung Disease RiskVaping may seem safer than smoking cigarettes, but it won’t protect you from lung damage.
Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...
Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease.
3don MSN
A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy ...
Inpatient pulmonary rehabilitation significantly enhances functional independence in patients with chronic lung disease and ...
An occasional cough helps clear irritants and secretions from your lungs and prevents infection. But if you develop a chronic cough that persists for weeks, you should find out if you have a medical ...
Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...
Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results